Tired of managing glaucoma with daily eye drops?
iDose® TR is an FDA‑approved implant designed to continuously deliver medication inside the eye — helping reduce the burden of daily drops.
What is iDose® TR?
iDose® TR is a tiny implant placed in the eye by an eye doctor to help lower eye pressure in people with open-angle glaucoma or ocular hypertension.
Designed to help provide long-term eye pressure control, iDose® TR offers an alternative approach to managing glaucoma.
Why patients consider iDose® TR
- Long-term eye pressure control
- No daily eye drops to remember
- In clinical studies, 8 out of 10 people were free of prescription eye drops at 12 months with iDose® TR
FDA‑approved treatment
Studied in clinical trials
Recommended by eye care professionals
Beyond daily eye drops
iDose TR is designed to help address the challenges of daily eye drops by delivering medication directly inside the eye – without the daily routine of drops.
iDose TR was proven safe and effective in clinical studies—8 out of 10 people were completely free of prescription eye drops at 12 months with iDose TR.
Ready to explore your options?
Find an eye doctor who can help determine whether iDose TR may be right for you.
Find a Doctor
Important Safety Information
iDose TR is gently placed directly inside your eye by your eye doctor.
You should not have iDose TR if you have an infection or suspected infection in your eye or the area surrounding your eye, have corneal endothelial cell dystrophy, a condition in which the clear front layer of your eye (cornea) has lost its ability to work normally as this can cause vision problems, have had a corneal transplant or cells transplanted to the inner layer of the cornea (endothelial cell transplant), are allergic to any of its ingredients, and/or have narrow angles (the iris and the cornea are too close together).
The most common side effect of iDose TR was increased eye pressure. Other common side effects were inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness and reduced clearness of vision.
If you have additional questions, please contact your doctor. For full Prescribing Information click here.
Approved Uses
iDose TR (travoprost intracameral implant) is a prescription medicine and drug delivery system for the eye approved to lower eye pressure in patients with open-angle glaucoma or high eye pressure (ocular hypertension).
You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also call Glaukos at 1-855-918-1504.